Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States

Autor: Kalirai S, Ivanova JI, Perez-Nieves M, Stephenson JJ, Hadjiyianni I, Grabner M, Pollom RD, Geremakis C, Reed BL, Fisher L

Publikováno v: Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 1023-1033 (2020)

Samaneh Kalirai,1 Jasmina I Ivanova,2 Magaly Perez-Nieves,1 Judith J Stephenson,3 Irene Hadjiyianni,1 Michael Grabner,3 Roy Daniel Pollom,1 Caroline Geremakis,3 Beverly L Reed,1 Lawrence Fisher4 1Eli Lilly and Company, Indianapolis, IN, USA; 2Analysi

Externí odkaz: https://doaj.org/article/ee0bcfb9873f45e1941eba8d2c0c710c

Treatment Patterns and Outcomes, Before and After Humulin R U-500 Initiation, Among High-Dose Type 2 Diabetes Mellitus Patients in the United States.

Autor: Hood RC; Endocrine Clinic of Southeast Texas, Beaumont, Texas., Borra S; STATinMED Research, Plano, Texas., Fan L; Eli Lilly and Company, Indianapolis, Indiana., Pollom RD; Eli Lilly and Company, Indianapolis, Indiana., Huang A; STATinMED Research, Plano, Texas., Chen J; Eli Lilly and Company, Indianapolis, Indiana. Electronic address: whjane@gmail.com.

Publikováno v: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2021 Aug; Vol. 27 (8), pp. 798-806. Date of Electronic Publication: 2021 Jun 03.

Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C).

Autor: Martens TW; International Diabetes Center, Minneapolis, MN, USA., Bergenstal RM; International Diabetes Center, Minneapolis, MN, USA., Pearson T; Innovative Healthcare Designs, LLC, Minneapolis, MN, USA., Carlson AL; International Diabetes Center, Minneapolis, MN, USA., Scheiner G; Integrated Diabetes Services, Wynnewood, PA, USA., Carlos C; The University of Texas Health Science Center, San Antonio, TX, USA., Liao B; Eli Lilly and Company, Indianapolis, IN, USA., Syring K; Eli Lilly and Company, Indianapolis, IN, USA., Pollom RD; Eli Lilly and Company, Indianapolis, IN, USA.

Publikováno v: Postgraduate medicine [Postgrad Med] 2021 Apr; Vol. 133 (3), pp. 253-264. Date of Electronic Publication: 2020 Dec 14.

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully.

Autor: Polonsky WH; Behavioral Diabetes Institute, San Diego, CA, USA.; Department of Psychiatry, University of California San Diego, San Diego, CA, USA., Arsenault J; CIUSSS-Jewish General Hospital Endocrinology, Montreal, QC, Canada., Fisher L; Family and Community Medicine, University of California School of Medicine, San Francisco, CA, USA., Kushner P; Family Medicine, University of California School of Medicine, Irvine, CA, USA., Miller EM; High Lakes Health Care, Bend, OR, USA., Pearson TL; Innovative Health Care Designs, Minneapolis, MN, USA., Tracz M; Department of Diabetology and Internal Medicine, Warsaw Medical University, Warsaw, Poland., Harris S; Western Center For Public Health and Family Medicine, Western University, London, ON, Canada., Hermanns N; Research Institute of Diabetes Academy Mergentheim (FIDAM), Bad Mergentheim, Germany., Scholz BM; Diabetologische Schwerpunktpraxis, Hamburg, Germany., Pollom RK; Eli Lilly and Company, Indianapolis, IN, USA., Perez-Nieves M; Eli Lilly and Company, Indianapolis, IN, USA., Pollom RD; Eli Lilly and Company, Indianapolis, IN, USA., Hadjiyianni I; Eli Lilly and Company, Indianapolis, IN, USA.

Publikováno v: International journal of clinical practice [Int J Clin Pract] 2017 Aug; Vol. 71 (8). Date of Electronic Publication: 2017 Jul 23.

BIOSIMILARS AND NEW INSULIN VERSIONS.

Autor: Peters AL, Pollom RD, Zielonka JS, Carey MA, Edelman SV

Publikováno v: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2015 Dec; Vol. 21 (12), pp. 1387-94. Date of Electronic Publication: 2015 Sep 04.